Leveraging CRO Partnerships
Many biopharmaceutical and medical device companies turn to Contract Research Organizations (CROs) when conducting clinical trials. CROs look to technology leaders like Phase Forward to provide EDC, CDMS and safety technology solutions to create operational efficiencies and reduce costs. For this reason, Phase Forward has developed partnerships with leading CROs to provide customers with end-to-end solutions for clinical development, leveraging our combined areas of expertise and technology innovation.
Phase Forward’s CRO Advantage Program is designed specifically to meet the needs of contract research organizations across a wide variety of geographies, market segments and adoption models. This formal partner program offers several customizable support levels to help CROs of varying sizes and types leverage Phase Forward’s technology platform and industry experience.
Learn more about our CRO Advantage Program
GleneaglesCRC
GleneaglesCRC, an Asian-based contract research organization, has selected Phase Forward’s Clintrial™ software for use in their Clinical Data Management units in Singapore, the Philippines and China. In addition to selecting the Clintrial software for use in its own trials, GleneaglesCRC offers localized support for Phase Forward’s InForm™ electronic data capture (EDC) product.
ICON
ICON is a rapidly growing, global clinical research organization that specializes in the strategic development, management and analysis of programs that support all stages of clinical development – from compound selection to Phase I-IV clinical studies. As a member of Phase Forward's CRO Advantage Program, ICON offers its clients Phase Forward's market-leading EDC solution, InForm™, and further capitalizes on the company's around-the-clock, multilingual technical support services.
www.iconclinical.com
PAREXEL
PAREXEL is one of the largest biopharmaceutical outsourcing organizations in the world and is committed to providing solutions that expedite time-to-market and peak market penetration. As part of that commitment, PAREXEL offers Phase Forward's InForm and Clintrial solutions to their customers as well as the Clintrace application for adverse event reporting. As one of Phase Forward’s most established partners, PAREXEL offers exceptional experience and expertise in delivering Phase Forward’s solutions to its customers.
PharmalinkFHI
PharmaLinkFHI, a leading electronic clinical research organization (eCRO), is a longtime strategic partner that uses Phase Forward’s InForm Web-based EDC solution. With the InForm system, PharmaLink can help its clients quickly and efficiently access, analyze and report critical clinical data. Because the InForm platform offers enterprise-level scalability – to thousands of sites and tens of thousands of patients – and extensive functionality in an intuitive user interface, clinical development staff can accomplish their work more quickly and with greater accuracy.
Quintiles
Quintiles Transnational Corporation, the leading Pharmaceutical Services provider, works with many clients requiring sophisticated, global trial and safety management capabilities. Partnering with Phase Forward, Quintiles has standardized on the InForm EDC platform, as well as the Clintrace adverse event reporting technology to fully leverage their safety management technologies and best-practice methodologies to run safe, efficient trials for their clients worldwide.
SGS Life Science Services
SGS Life Science Services, a business unit of the SGS Group, has 30 years of experience as a global contract service organization, providing integrated solutions from preclinical activities to Phase I through IV trials, bio-analytical and QC testing in Europe, North America and Asia. SGS has designated Phase Forward as a preferred partner, expanding its use of Phase Forward technology to include the Clintrial™ clinical data management system, the Clintrace™ adverse event reporting tool, and most recently, the industry-leading InForm™ ITM EDC platform.
www.sgs.com/clinicalresearchAcademic Research Organizations
In addition to our CRO partner program, Phase Forward has developed partnerships with leading Academic Research Organizations (AROs), including:
Harvard Clinical Research Institute
HCRI currently utilizes the InForm solution to conduct cardiac device trials over the next several years. As part of its strategy to create an integrated clinical trial environment, HCRI also uses Phase Forward’s Clintrial and Clintrace systems. Leveraging Phase Forward’s technologies, HCRI expects to improve the speed and accuracy of its clinical trials, increase productivity, and lower the cost of clinical research.